Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Rapid clinical recovery of a SARS-CoV-2 infected common variable immunodeficiency patient following the infusion of COVID-19 convalescent plasma

2021; BioMed Central; Volume: 17; Issue: 1 Linguagem: Inglês

10.1186/s13223-021-00518-5

ISSN

1710-1492

Autores

Luciana C. Ribeiro, Bruno Deltreggia Benites, Raisa G. Ulaf, Thyago A. Nunes, Carolina Costa-Lima, Marcelo Addas‐Carvalho, José Luiz Proença-Módena, Fabiana Granja, Vitor Antonio da Costa, Adriana da Silva Santos Duarte, Audrey Basso Zangirolami, Emerson Clayton Amaro, Eli Mansour, Ricardo de Lima Zollner, Lı́cio A. Velloso,

Tópico(s)

Pneumocystis jirovecii pneumonia detection and treatment

Resumo

Common variable immunodeficiency is the most prevalent symptomatic primary immunodeficiency in adults. Affected patients fail to mount an appropriate humoral response against community acquired infectious diseases and recent reports have provided data supporting the increased susceptibility of these patients to severe SARS-CoV-2 infections. In this context, the infusion of COVID-19 convalescent plasma could represent an effective therapeutic strategy.

Referência(s)